Gaby Reckzügel
Boehringer Ingelheim Pharma
Referent:innen
Dr Armin Hauk
Sartorius Stedim Biotech
Dr Andreas Nixdorf
SGS Institut Fresenius
Zielsetzung
Over the last years, the requirements on the assessment of substances that could leach into the drug product in the course of its life cycle have increased considerably.
The kind of leachable you would have to look for can vary from organic oligomers and catalyst residues to heavy metals – to name a few. Due to the resulting complexity, it is very important to consider the potential risk factors associated with leaching substances already at a very early stage in process development.
Packaging materials have been in the focus of such investigations for a long time as the contact time between drug product and packaging material is rather long.
But in addition you have also to consider other possible sources of contamination. Recently, particular attention was paid to devices and equipment used in the production process itself, e.g. filters, bags, tubes. The trend towards single-use equipment might relieve the pressure on cleaning validation and the need to introduce control strategies along the supply chain to avoid unintentional added impurities in materials. At the same time leachables/extractables testing will become a topic of major concern.
Within the scope of this GMP Education Course, all relevant aspects of Pharmacopoeia/GMP - compliant leachables and extractables testing will be addressed ranging from regulatory requirements to routine extractables testing in quality control.
Experienced industry speakers share their in-depth knowledge with you.
The kind of leachable you would have to look for can vary from organic oligomers and catalyst residues to heavy metals – to name a few. Due to the resulting complexity, it is very important to consider the potential risk factors associated with leaching substances already at a very early stage in process development.
Packaging materials have been in the focus of such investigations for a long time as the contact time between drug product and packaging material is rather long.
But in addition you have also to consider other possible sources of contamination. Recently, particular attention was paid to devices and equipment used in the production process itself, e.g. filters, bags, tubes. The trend towards single-use equipment might relieve the pressure on cleaning validation and the need to introduce control strategies along the supply chain to avoid unintentional added impurities in materials. At the same time leachables/extractables testing will become a topic of major concern.
Within the scope of this GMP Education Course, all relevant aspects of Pharmacopoeia/GMP - compliant leachables and extractables testing will be addressed ranging from regulatory requirements to routine extractables testing in quality control.
Experienced industry speakers share their in-depth knowledge with you.
Zielgruppe
The course is designed for personnel of pharmaceutical companies and their suppliers who
- are responsible for qualification of extractables/leachables in quality control,
- perform leachables/extractables testing,
- work in quality control of packaging materials,
- choose and define polymeric, glass and rubber materials in process development,
- choose and define Single Use Equipment for manufacturing,
- develop materials sourcing strategies.
Technical Details:
To participate in an on demand training course or webinar, you do not need any software. The recordings are made available via a streaming server. In general, the recording is provided in MP4 format, which any PC (Microsoft Windows, Apple IOS) or tablet can easily display.
Timing and Duration:
Timing and Duration:
When you register for the on demand Training course or webinar you can decide at what date you want to follow the training course online. For a 1-day training course you will have 2 days in which the stream is available (for 2-day training course 3 days and for a 3-day training course 4 days). Within in this timeframe you can start & stop the stream according to your needs.
In time before the scheduled date (your desired date) you will receive an e-mail from us with a link for direct participation as well as your log-in data.
Training Course Documentation and Certificate:
Training Course Documentation and Certificate:
The presentations will be made available as PDF files via download shortly before the online training course. After the event, you will automatically receive your certificate of participation.
Programm
Extractables & Leachables: Regulatory and Scientific Perspectives
- What are Extractables and Leachables?
- Regulatory requirements of EMA and US-FDA
- Compendial requirements
- Scientific aspects
Best Practices for Controlled Extraction Studies
- PQRI recommendations for Extractables studies
- USP <1663> Assessment of Extractables from pharmaceutical packaging systems
- PQRI recommendations and ICH Guidelines: Safety thresholds and Permitted Daily Exposure
Leachable Studies Design Strategy in Complex Formulated Drugs
- Establishment of Leachables Strategies, the Design Space
- Extractables & Leachables Correlation
- Non-targeted Screening vice versa Validated Target Analysis
- Drug Matrices: Impacts on Leachables Discovery and Identification
- The Large Volume Problem, Analytical Uncertainty, Design Space Solutions
- The Leachables Shelf Life Program
E&L for Single Use Systems as Elements of Process Qualification/Validation and Safety Assessment - Part 1
- Introduction on Single Use Systems (SUS/SUT)
- The Need for E&L Data for SUS in biopharmaceutical processes
- E&L Data for SUS as elements of the qualification triangle
- The concerns with E&L regarding process performance, product quality and patient safety
E&L for Single Use Systems as Elements of Process Qualification/Validation and Safety Assessment - Part 2
- Extractables vs. simulation studies for SUS
- Requirements on E&L Data to be suitable for a risk assessment
- The need for extrapolation of SUS extractables data towards process equipment related leachables (PERLs) and towards process conditions
- Modelling approaches as mitigation concepts in the SUS area
Recording from 02 July 2020
Duration of recording: 4 h 43 min.
Duration of recording: 4 h 43 min.
| ECA-Member*: | € 890,- |
| Regular Fee*: | € 990,- |
| EU/GMP Inspectorates*: | € 445,- |
| APIC Member Discount*: | € 950,- |
Alle Preise zzgl. MwSt. Wichtige Hinweise zur Umsatzsteuer.
* auch unkompliziert per Kreditkarte bezahlbar
Weitere Termine vor Ort
Weitere Termine vor Ort nicht verfügbar
Weitere Termine online
Weitere Termine online nicht verfügbar
This course is part of the GMP Certification Programme "ECA Certified Quality Control Manager"
Haben Sie noch Fragen?
Wir stehen Ihnen für weitere Auskünfte gerne zur Verfügung.
E-Mail: info@concept-heidelberg.de
Teilnehmerstimmen
Sonderkonditionen DB BahnTeilnehmerstimmen - das sagen andere über unsere Seminare:
